Transcat, Inc.
TRNSIndustrialsNASDAQSpecialty Business Services · Last scanned May 30, 2026
Scan Results
Daily timeframeTranscat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. Valued at $789.5M, TRNS is a small-cap name in its sector. It operates through two segments, Service and Distribution.
Market Cap
$789.5M
Beta
0.68
P/E (TTM)
148.28
P/E (Fwd)
39.45
EPS (TTM)
$0.57
EPS (Fwd)
$2.14
ROE
1.8%
ROA
2.3%
Cash
$4.9M
Total Debt
$133.3M
Free CF
$21.1M
52W Change
-1.1%
Annual Financials
Cash vs Debt
The company holds $4.9M in cash, though total debt stands at $133.3M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $21.1M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of 1.8% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 2.3% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $205.0M (2022) to $331.9M (2026), reflecting a 62% increase over the period.
TRNS's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. Transcat, Inc. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. The elevated P/E ratio means the stock is priced for significant future growth. If earnings disappoint, the price correction could be sharp. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Transcat, Inc. and its sector.